| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8342911 | Molecular Genetics and Metabolism | 2018 | 49 Pages |
Abstract
These consensus recommendations help advance Fabry disease management by considering the balance between anticipated clinical benefits and potential therapy-related challenges in order to facilitate individualized treatment, optimize patient care and improve quality of life.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Christoph Wanner, Michael Arad, Ralf Baron, Alessandro Burlina, Perry M. Elliott, Ulla Feldt-Rasmussen, Victor V. Fomin, Dominique P. Germain, Derralynn A. Hughes, Ana Jovanovic, Ilkka Kantola, Aleš Linhart, Renzo Mignani, Lorenzo Monserrat,